European IP

News

Supreme Court provides guidance on post-sale confusion in Umbro ruling

The UK Supreme Court has handed down its judgment in Iconix Luxembourg Holdings SARL v Dream Pairs Europe Inc and another, reversing the Court of Appeal’s decision and providing important guidance on ...

The Pre-Launch Patent Playbook

The Pre-Launch Patent Playbook Search Strategy: Streamlined Approaches to Competitor Risk Identification

In the second webinar of a three-part series on IP risk analysis, on 17 June 2025, Emer Bollinghaus, Barbara Durling, and Alex Worley explored the use of strategic patent searching to streamline your ...

Case law

CJEU delivers judgment in Case C-17/24, CeramTec GmbH v Coorstek Bioceramics LLC

The CJEU has delivered its judgment in Case C-17/24, CeramTec GmbH v Coorstek Bioceramics LLC, on 19 June 2025.

G1/24: EPO Enlarged Board’s decision extinguishes uncertainty on patent claim interpretation

Yesterday, the Enlarged Board of Appeal issued their decision on case G1/24 regarding how patent claims must be interpreted when assessing patentability.

News

Three WTR global leaders recognised at Kilburn & Strode, “the best firm to work with in the United Kingdom.”

We are proud that three of our trade mark partners, Iain Stewart, Ryan Pixton and Rowena Tolley, have been named as Global Leaders by World Trademark Review 2025.

Thoughts

R 12/21: Petition for review succeeds after EPO Board of Appeal found to violate right to be heard

The petition for review procedure under Article 112a EPC allows parties adversely affected by a decision of the Board of Appeal (BoA) to request a review by the Enlarged Board of Appeal (EBoA). The ba...

CRISPR

The CRISPR therapeutics landscape in 2025

Once confined to science fiction, precise genetic engineering has become a reality and has profoundly impacted modern medicine.

The Pre-Launch Patent Playbook

The Pre-Launch Patent Playbook: Aligning Patent Risk Assessment with Your Innovation Development Workflows

On 3 June 2025, we held the first webinar in our Pre-Launch Patent Playbook series. Barbara Durling hosted Rike Dekker and Emer Bollinghaus for a discussion on: Aligning Patent Risk Assessment with Yo...

Case law

Dosage regimen patents at the EPO part (II): Recent case law

Dosage regimen patent applications are typically filed a few years after the original application to compounds and their medical uses. Often a clinical trial will already be underway, investigating di...